全文获取类型
收费全文 | 957篇 |
免费 | 129篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 17篇 |
妇产科学 | 99篇 |
基础医学 | 224篇 |
口腔科学 | 26篇 |
临床医学 | 150篇 |
内科学 | 122篇 |
皮肤病学 | 7篇 |
神经病学 | 33篇 |
特种医学 | 17篇 |
外科学 | 94篇 |
综合类 | 27篇 |
一般理论 | 4篇 |
预防医学 | 114篇 |
眼科学 | 41篇 |
药学 | 88篇 |
肿瘤学 | 14篇 |
出版年
2021年 | 11篇 |
2020年 | 6篇 |
2019年 | 11篇 |
2018年 | 18篇 |
2017年 | 13篇 |
2016年 | 10篇 |
2015年 | 20篇 |
2014年 | 24篇 |
2013年 | 21篇 |
2012年 | 33篇 |
2011年 | 48篇 |
2010年 | 28篇 |
2009年 | 23篇 |
2008年 | 43篇 |
2007年 | 43篇 |
2006年 | 44篇 |
2005年 | 36篇 |
2004年 | 42篇 |
2003年 | 34篇 |
2002年 | 36篇 |
2001年 | 38篇 |
2000年 | 38篇 |
1999年 | 35篇 |
1998年 | 16篇 |
1997年 | 17篇 |
1996年 | 7篇 |
1995年 | 11篇 |
1994年 | 9篇 |
1992年 | 40篇 |
1991年 | 35篇 |
1990年 | 32篇 |
1989年 | 18篇 |
1988年 | 22篇 |
1987年 | 19篇 |
1986年 | 18篇 |
1985年 | 21篇 |
1984年 | 21篇 |
1983年 | 9篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1980年 | 10篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1976年 | 11篇 |
1975年 | 7篇 |
1973年 | 6篇 |
1970年 | 7篇 |
1968年 | 8篇 |
1967年 | 7篇 |
1966年 | 5篇 |
排序方式: 共有1086条查询结果,搜索用时 15 毫秒
21.
22.
23.
Rajeev Ramchand Enchanté Franklin Elizabeth Thornton Sarah Deland Jeffrey Rouse 《Death Studies》2017,41(6):368-375
To validate warning signs for suicide, researchers interviewed 20 respondents, representing 17 suicides in Orleans Parish, Louisiana, about characteristics of the decedent in the year, month, and days preceding the death. Decedents did exhibit behaviors consistent with existing warning signs, but these were rarely new behaviors present 7 days prior to the suicide but not previously. Research is needed to continue to test warning signs for suicide, and education campaigns that teach warning signs may not be relevant for preventing suicide among those in mental health treatment or involved in the criminal justice system. 相似文献
24.
25.
26.
M. Allison Arwady Luke Bawo Jennifer C. Hunter Moses Massaquoi Almea Matanock Bernice Dahn Patrick Ayscue Tolbert Nyenswah Joseph D. Forrester Lisa E. Hensley Benjamin Monroe Randal J. Schoepp Tai-Ho Chen Kurt E. Schaecher Thomas George Edward Rouse Ilana J. Schafer Satish K. Pillai Kevin M. De Cock 《Emerging infectious diseases》2015,21(4):578-584
Over the span of a few weeks during July and August 2014, events in West Africa changed perceptions of Ebola virus disease (EVD) from an exotic tropical disease to a priority for global health security. We describe observations during that time of a field team from the Centers for Disease Control and Prevention and personnel of the Liberian Ministry of Health and Social Welfare. We outline the early epidemiology of EVD within Liberia, including the practical limitations on surveillance and the effect on the country’s health care system, such as infections among health care workers. During this time, priorities included strengthening EVD surveillance; establishing safe settings for EVD patient care (and considering alternative isolation and care models when Ebola Treatment Units were overwhelmed); improving infection control practices; establishing an incident management system; and working with Liberian airport authorities to implement EVD screening of departing passengers. 相似文献
27.
28.
Madigan Cory G. Adams Michael B. Chu Chu-Chiao Dinkha Laith R. Farrell Samuel J. Hoard Robert T. Keithler Andrea N. Loudermilk Kevin A. Rouse Jessica Walker Brandon L. Williams Susan G. Wyatt Andrew C. Gore Rosco S. Thomas Dustin M. 《The international journal of cardiovascular imaging》2021,37(12):3583-3588
The International Journal of Cardiovascular Imaging - To compare overall number of downstream tests and total costs between negative exercise stress echocardiograms (ESE) or cardiac computed... 相似文献
29.
Yael I. Nillni Suzanne L. Pineles Samantha C. Patton Matthew H. Rouse Alice T. Sawyer Ann M. Rasmusson 《Journal of traumatic stress》2015,28(1):1-7
The menstrual cycle has been implicated as a sex‐specific biological process influencing psychological symptoms across a variety of disorders. Limited research exists regarding the role of the menstrual cycle in psychological symptoms among women with posttraumatic stress disorder (PTSD). The current study examined the severity of a broad range of psychological symptoms in both the early follicular (Days 2–6) and midluteal (6–10 days postlutenizing hormone surge) phases of the menstrual cycle in a sample of trauma‐exposed women with and without PTSD (N = 49). In the sample overall, total psychological symptoms (d = 0.63), as well as depression (d = 0.81) and phobic anxiety (d = 0.81) symptoms, specifically, were increased in the early follicular compared to midluteal phase. The impact of menstrual cycle phase on phobic anxiety was modified by a significant PTSD × Menstrual Phase interaction (d = 0.63). Women with PTSD reported more severe phobic anxiety during the early follicular versus midluteal phase, whereas phobic anxiety did not differ across the menstrual cycle in women without PTSD. Thus, the menstrual cycle appears to impact fear‐related symptoms in women with PTSD. The clinical implications of the findings and future research directions are discussed. 相似文献
30.
Helen Winter Erica Egizi Stephen Murray Ngozi Erondu Ann Ginsberg Doris J. Rouse Diana Severynse-Stevens Elliott Pauli 《Antimicrobial agents and chemotherapy》2015,59(2):1219-1224
This study assessed the effects of rifapentine or rifampin on the pharmacokinetics of a single dose of bedaquiline and its M2 metabolite in healthy subjects using a two-period single-sequence design. In period 1, subjects received a single dose of bedaquiline (400 mg), followed by a 28-day washout. In period 2, subjects received either rifapentine (600 mg) or rifampin (600 mg) from day 20 to day 41, as well as a single bedaquiline dose (400 mg) on day 29. The pharmacokinetic profiles of bedaquiline and M2 were compared over 336 h after the administration of bedaquiline alone and in combination with steady-state rifapentine or rifampin. Coadministration of bedaquiline with rifapentine or rifampin resulted in lower bedaquiline exposures. The geometric mean ratios (GMRs) and 90% confidence intervals (CIs) for the maximum observed concentration (Cmax), area under the concentration-time curve to the last available concentration time point (AUC0–t), and AUC extrapolated to infinity (AUC0–inf) of bedaquiline were 62.19% (53.37 to 72.47), 42.79% (37.77 to 48.49), and 44.52% (40.12 to 49.39), respectively, when coadministered with rifapentine. Similarly, the GMRs and 90% CIs for the Cmax, AUC0–t, and AUC0–inf of bedaquiline were 60.24% (51.96 to 69.84), 41.36% (37.70 to 45.36), and 47.32% (41.49 to 53.97), respectively, when coadministered with rifampin. The Cmax, AUC0–t, and AUC0–inf of M2 were also altered when bedaquiline was coadministered with rifapentine or rifampin. Single doses of bedaquiline, administered alone or with multiple doses of rifapentine or rifampin, were well tolerated, with no safety concerns related to coadministration. Daily administration of rifapentine to patients with tuberculosis presents the same drug interaction challenges as rifampin and other rifamycins. Strong inducers of the cytochrome P450 isoenzyme CYP3A4 should be avoided when considering the use of bedaquiline. (This study is registered at clinicaltrials.gov under identifier .) NCT02216331相似文献